Angiotensin Converting Enzyme Inhibition in Children With Mitral Regurgitation

NCT00113698 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

5

Enrollment

OTHER

Sponsor class

Stopped lower than expected enrollment

Conditions

Heart Defects, Congenital
Heart Septal Defects, Ventricular
Heart Failure, Congestive

Interventions

DRUG: Enalapril
OTHER: Placebo

Sponsor

University of Utah

Collaborators

[object Object]
[object Object]